We provide value to our customers by gathering, confirming, updating and disseminating information about industrial plants and their spending activities around the world so they can make timely and intelligent business decisions. Learn more about ... Industrial Info Financials, 3 days ago
If you look at the biosimilars market as a global whole, the sum total of revenue generated by the follow-on crowd just barely crossed into blockbuster territory in 2013, according to a new study from Allied Marketing Research. But that $1.3 billion ...FierceBiotech, 1 week ago
Pearl Lin Investors, friends from the media, ladies and gentlemen, good afternoon. I am IR Officer Pearl Lin. Welcome to the second quarter results investor conference. Today, we have four speakers, Mr. Paul Peng, the President; Mr. F.C.Seeking Alpha, 1 day ago Newell Rubbermaid's (NWL) CEO Michael Polk on Q2 2014 Results - Earnings Call Transcript Seeking Alpha, 1 day ago Anika Therapeutics' (ANIK) CEO Charles Sherwood on Q2 2014 Results - Earnings Call Transcript Seeking Alpha, 1 day ago Rovi's (ROVI) CEO Thomas Carson on Q2 2014 Results - Earnings Call Transcript Seeking Alpha, 1 day ago
European Commission MEMO Brussels, 31 July 2014 See also IP/14/890 1. General information about Intellectual Property Rights (IPRs) Why is it important to protect IPRs? As the EU's 2020 Strategy underlines, the protection of IPRs is ...European Commission, 1 day ago
07/30/14 - 06:31 AM EDT LONDON ( The Deal ) -- European stock indices were little changed on Wednesday as a new round of U.S. and European Union sanctions against Russia over its suspected military backing of separatists in Ukraine coincided with ...TheStreet.com, 2 days ago
Obinutuzumab ( Gazyvaro , Roche) is now approved in Europe for the treatment of chronic lymphocytic leukemia (CLL), specifically for use in combination with chlorambucil in patients with previously untreated disease who have comorbidities making ...General Medicine eJournal, 3 days ago
Source: Applied Clinical Trials EmailPrint SaveLicense The patent cliff that rocked big pharma is now starting to reverberate in companies developing generic alternatives. As the slate of top-selling pharmaceuticals going off-patent declines, ...Applied Clinical Trials, 2 days ago Pfizer's Incoming Patent Cliff Motley Fool, 1 week ago
An exciting time in Canadian Competition Bureau policy substantive guidance on reverse payment patent settlement agreements may be imminent?
As part of the Canadian Competition Bureau's revisions to its IP Enforcement Guidelines, some stakeholders have requested guidance on new issues of concern in the Competition Law area including reverse payment patent settlement agreements. Prior to ...Lexology, 1 week ago
Bodyshop Revolution Worldwide announced the official launch of business operations in North America including the United States. The organization equips bodyshops to increase efficiency and reduce cycle time by up to 60%, guaranteed. We are proud ...Search-Autoparts.com, 1 week ago
Photo: iStockphoto Typically, the first step in turning an idea into money is to patent it. Starting this process raises the questions How much does a patent cost? and How long will it take? Unfortunately, there are no fixed answers to these ...Spectrum Online, 1 week ago
on your WebpageAdd Widget >Get your members hooked!